Academic Pediatrics
Volume 9, Issue 3 , Pages 179-184 , May 2009

Antibiotic Selection for Purulent Skin and Soft-Tissue Infections in Ambulatory Care: A Decision-Analytic Approach

Received 30 December 2008 ,Accepted 5 February 2009.

References 

  1. Hersh AL, Chambers HF, Maselli JH, Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med. 2008;168:1585–1591
  2. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. EMERGEncy ID Net Study Group Methicillin-resistant S aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666–674
  3. Stevens DL, Bisno AL, Chambers HF, et al. Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41:1373–1406
  4. Zaoutis TE, Toltzis P, Chu J, et al. Clinical and molecular epidemiology of community-acquired methicillin-resistant Staphylococcus aureus infections among children with risk factors for health care–associated infection: 2001–2003. Pediatr Infect Dis J. 2006;25:343–348
  5. Hultén KG, Kaplan SL, Gonzalez BE, et al. Three-year surveillance of community onset health care-associated Staphylococcus aureus infections in children. Pediatr Infect Dis J. 2006;25:349–353
  6. Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA, and Participants in the CDC-Convened Experts’ Meeting on Management of MRSA in the Community. Strategies for clinical management of MRSA in the community: summary of an experts’ meeting convened by the Centers for Disease Control and Prevention. March 2006. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/ar/CAMRSA_ExpMtgStrategies.pdf. Accessed February 19, 2009.
  7. Baker CJ. Large CA-MRSA disease burden mandates prompt diagnosis, appropriate management. AAP News. 2007;28:1;9
  8. Kaplan SL. Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J. 2005;24:457–458
  9. Liu C, Graber CJ, Karr M, et al. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004–2005. Clin Infect Dis. 2008;46:1637–1646
  10. Daum RS. Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med. 2007;357:380–390
  11. Phillips S, MacDougall C, Holdford DA. Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus. Ann Pharmacother. 2007;41:13–20
  12. Daneman N, Low DE, McGeer A, et al. At the threshold: defining clinically meaningful resistance thresholds for antibiotic choice in community-acquired pneumonia. Clin Infect Dis. 2008;46:1131–1138
  13. Le TP, Miller LG. Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis. Clin Infect Dis. 2001;33:615–621
  14. Evans RS, Classen DC, Pestotnik SL, et al. Improving empiric antibiotic selection using computer decision support. Arch Intern Med. 1994;154:878–884
  15. Evans RS, Pestotnik SL, Classen DC, et al. A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med. 1998;338:232–238
  16. Beardsley JR, Williamson JC, Johnson JW, et al. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest. 2006;130:787–793
  17. Hersh AL, Cabana MD, Gonzales R, Shenkin BN, Cho CS. Pediatricians' perspectives on the impact of MRSA in primary care: a qualitative study. BMC Pediatr. 2009;in press
  18. Ellingson KD, Gorwitz R, Pearson ML. Variability in Practice Patterns for Outpatient Management of Staphylococcal Skin and Soft Tissue Infections—2005. San Diego, Calif: Infectious Diseases Society of America; 2007;
  19. McCaig LF, McDonald LC, Mandal S, Jernigan DB. Staphylococcus aureus–associated skin and soft tissue infections in ambulatory care. Emerg Infect Dis. 2006;12:1715–1723
  20. Ruhe JJ, Smith N, Bradsher RW, Menon A. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis. 2007;44:777–784
  21. Chuck EA, Frazee BW, Lambert L, McCabe R. The benefit of empiric treatment for methicillin-resistant Staphylococcus aureus. J Emerg Med. In press.

PII: S1876-2859(09)00050-3

doi: 10.1016/j.acap.2009.02.002

Academic Pediatrics
Volume 9, Issue 3 , Pages 179-184 , May 2009

Article Tools

* Image Usage & Resolution